Khashayar Ahmadmehrabi is a Ann Arbor, Michigan based male rheumatologist who is specialized in Rheumatology. Active license number of Khashayar Ahmadmehrabi for Rheumatology is 4301512155 in Michigan. Khashayar Ahmadmehrabi treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Khashayar Ahmadmehrabi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
4350 Jackson Rd Ste 320, Ann Arbor, Michigan, 48103-1890
Phone:
734-426-1931
Fax:
734-426-9021
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1083174577
NPI Enumeration Date:
21 Mar, 2019
NPI Last Update On:
24 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Khashayar Ahmadmehrabi are as mentioned below.
License Number
Specialization
State
Status
4301512155
Rheumatologist
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
24 Frank Lloyd Wright Dr Ste J2000, Ann Arbor, Michigan
Zip:
48105-9484
Phone Number:
734-747-6766
Fax Number:
734-222-3100
Patients can reach Khashayar Ahmadmehrabi at 4350 Jackson Rd Ste 320, Ann Arbor, Michigan or can call to book an appointment on 734-426-1931. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.